Alligator Bioscience announces Immuno-oncology Research Collaboration and License Agreement with Orion Corporation Read more
NRx Pharmaceuticals Announces Positive Safety Report for ZYESAMI (aviptadil) in NIH Sponsored ACTIV-3 Critical Care Study in Patients with Life-Threatening COVID-19 Read more
Roche receives FDA approval for first companion diagnostic to identify dMMR solid tumour patients eligible for anti-PD-1 immunotherapy Read more
FDA approves Jardiance (empagliflozin) to treat adults living with heart failure with reduced ejection fraction Read more
SomaLogic and Twist Bioscience Corporation announce partnership to discover novel therapeutic targets and antibodies Read more
Pfizer and BioNTech Announce Submission of Initial Data to U.S. FDA to Support Booster Dose of COVID-19 Vaccine Read more
GSK receives FDA accelerated approval for JEMPERLI (dostarlimab-gxly) for adult patients with mismatch repair-deficient (dMMR) recurrent or advanced solid tumours Read more
HDT Bio Announces Agreement with Korea’s Quratis to Co-Develop Innovative COVID-19 Vaccine in Asia Read more
Gritstone and CEPI Announce Agreement to Advance Second-Generation COVID-19 Vaccine Program (CORAL) Against SARS-CoV-2 Variants of Concern Read more